On Wednesday, June 1, 2016, the University of Pennsylvania Perelman School of Medicine’s Institute on Aging (IOA), Center for Neurodegenerative Disease Research (CNDR), and Penn Translational Neuroscience Center (PTNC) co-hosted their first Town Hall Meeting, open to all interested University of Pennsylvania researchers.
The idea behind this joint effort is to increase the awareness and knowledge of the variety of available National Institutes of Health (NIH) funding opportunities relating to Alzheimer’s disease and related disorders (ADRD) and the neurosciences, with many already underway here at Penn.
“In the last five years, NIH funding [for ADRD research] increased from $450 million to
nearly $1 billion,” explained John Q. Trojanowski, MD, PhD, IOA Director and CNDR Co-Director. “People who are not working in ADRD can get involved in this field. Penn is a hotbed of aging research, but there is always room to do more.”
Back in February of this year, NIA Director, Dr. Richard Hodes, MD paid a visit to the University of Pennsylvania to hear from Penn researchers and clinicians working in the fields of aging and neuroscience as well as immunology. During this visit, Dr. Hodes addressed many questions regarding the $2 billion NIH budget increase — with more than $350 million specifically earmarked for Alzheimer’s research — which was announced just a month prior. In response, Dr. Hodes broadly recommended and stressed the importance of making any and all connections to ADRD explicitly emphasized in upcoming proposals, without being misleading.
With that in mind, the main goal of this Town Hall Meeting was to encourage and welcome more collaboration across the Perelman School of Medicine within these areas of research — particularly with those whose past research has not yet explored such topics.
John Q. Trojanowski, MD, PhD discusses the goals and benefits of the Town Hall Meeting on ADRD Funding Opportunities:
Frances E. Jensen, MD, FACP discusses Neurosciences at Penn – Opportunities Overview:
Jerry Schellenberg, PhD discusses the new Penn Neurodegeneration Genomics Center and related resources at Penn:
For more information on the Town Hall Meeting, including a list of speakers, presentations, funding opportunities, current ADRD Grants at Penn, and more, click here.